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ZIRKONIA Y2O3 DAN CaO SEBAGAI PENGUAT DALAM BIOKOMPOSIT 
HIDROKSIAPATIT  
 
ABSTRAK 
 
 Biokomposit hidroksiapatit diperkuat zirkonia (ZrO2/HAp) telah difabrik 
untuk menambahbaik kekuatan dan keliatan patah bioseramik HAp tunggal. Y2O3-
ZrO2 dan CaO-ZrO2 komersial dipilih sebagai bahan penguat untuk matrik HAp. 
Sampel ZrO2/HAp telah dihasilkan dengan cara konvensional pemprosesan seramik, 
iaitu melibatkan pencampuran serbuk, pemadatar dan persinteran. Pemprosesan 
sampel dimulakan dengan pencampuran atau pengisaran-pencampuran untuk 
membandingkan kehasilan kedua-dua sistem ini. Hasil sifat fizikal dan mekanikal 
adalah lebih baik dengan penggunaan cara pengisaran-pencampuran. HAp yang 
diperkuatkan sebanyak 5 bt% Y2O3-ZrO2 komersial yang seterusnya ditambah dengan 
berlainan amaun CaF2 amaun (1, 3, 5, 7 and 9 bt%) sebagai pembantu sinter dalam 
biokomposit ZrO2/HAp. Sampel dipadat dengan mampatan ekapaksi sebanyak 90 
MPa. Sampel kemudian disinter pade suhu 1050°C sehingga 1250°C dalam udara 
selama 5 jam. Semakin tinggi amaun CaF2 digunakan, semakin besar kemungkinan 
fasa HAp dikekalkan. Kekuatan lentur dan keliatan patah optima dicapai ialah 61.10 
MPa dan 1.15 MPa.m1/2 selepas penambahan 3 bt% CaF2 (komposit 5YZH-3CF). 
Dengan ini, 3 dan 5 bt% CaF2 dipilih sebagai amaun optima. Dalam bahagian kedua, 
penambahan 5 dan 10 bt% CaO-ZrO2 dalam HAp dibanding dengan Y2O3-ZrO2 dari 
segi kesan kekuatan dan keliatan. Amaun CaF2 yang terpilih sebelum ini juga ditambah 
ke biokomposit CaO-ZrO2/HAp. Sifat mekanikal biokomposit CaO-ZrO2/HAp adalah 
lebih baik daripada optima HAp tunggal, iaitu kekuatan lentur dan ketahanan lentur 
ialah 54.77 MPa dan 1.33 MPa.m1/2 dengan ketumpatan 3.14 gcm-3. Bahagian terakhir 
xix 
 
adalah pengujian bioaktiviti biokomposit HAp diperkuat Y2O3 dan CaO-ZrO2. 
Pembentukan lapisan apatit dijumpai di atas permukaan sampel terpilih menandakan 
bioserasi dan potensi keupayaan pembentukan tulang. 
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Y2O3 AND CaO ZIRCONIA AS REINFORCEMENT FOR 
HYDROXYAPATITE BIOCOMPOSITE  
 
ABSTRACT 
  
 Zirconia reinforced hydroxyapatite (ZrO2/HAp) biocomposites were fabricated 
to improve the strength and fracture toughness of monolithic HAp. Commercial Y2O3-
ZrO2 and CaO-ZrO2 were selected as the reinforcement for the HAp matrix. The 
ZrO2/HAp samples were produced by conventional ceramic processing route. The 
samples were initially produced by pure mixing as well as milling-mixing system. 
Better physical and mechanical properties were observed from milling-mixing. 5 wt% 
of commercial Y2O3-ZrO2 was used to reinforce HAp and various amount of CaF2 (1, 
3, 5, 7 and 9 wt%) were added to the ZrO2/HAp biocomposite as sintering aid. Samples 
were compacted with a uniaxial pressure of 90 MPa. The samples were then sintered 
from 1050°C to 1250°C for 5 hours. The optimum flexural strength of 61.10 MPa and 
fracture toughness of 1.15 MPa.m1/2 was achieved by 3 wt% of CaF2 addition. From 
this study, 3 and 5 wt% of CaF2 were selected as optimum addition. Subsequently, 5 
and 10 wt% of CaO-ZrO2 were incorporated to HAp to improve the strength and 
toughness of the HAp as compared with Y2O3-ZrO2 addition. The selected amounts of 
CaF2 were also added to CaO-ZrO2/HAp biocomposites. The mechanical properties of 
CaO-ZrO2/HAp biocomposite were found to be better than the optimum properties of 
monolithic HAp. The biocomposite achieved better flexural strength of 54.77 MPa 
with higher density 3.14 gcm-3 and fracture toughness of 1.33 MPa.m1/2. The 
bioactivity test on both Y2O3 and CaO-ZrO2 reinforced HAp biocomposites revealed 
the formation of apatite layer on the surfaces, indicating the biocompatibility and 
potential bone forming ability. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Background 
Biomaterials are generally based on the groups of materials such as metals, 
polymers, and ceramics (Park & Lakes 2007; Hermansson 2014). Biomaterials based 
ceramics, also known as bioceramics, are found within all the classical ceramic 
families such as traditional ceramics, special ceramics, glasses, glass-ceramics, 
coatings, and chemically bonded ceramics (Hermansson 2014). Bioceramics can be 
classified into bioinert, bioactive and resorbable bioceramics (Hench 1991). 
Depending on the applications, type of bioceramics can be selected. For instance, hard 
tissue and bone replacements are synthesized mainly from bioactive ceramics such as 
dense non-porous bioglass, ceravital and hydroxyapatite (HAp) (Best et al. 2008).  
 
HAp, however, is the most largely used material than the others primarily 
because of its compositional and biological similarity to human bone, 
biocompatibility, bioactivity and osteoconduction characteristic (Jun et al. 2003; 
Sadjadi et al. 2010). It possesses exceptional biocompatibility and unique bioactivity, 
and it will form an artificial bone-like structure with the surrounding bone tissue when 
implanted (Hench & Wilson 1993). The reason for using hydroxyapatite as a bone 
substitute material is because the major constituent of bone is HAp and natural bone 
is approximately 70% hydroxyapatite by weight and 50% hydroxyapatite by volume 
(Shors & Holmes 1993; Vasconcelos 2012). HAp is frequently used for reconstruction 
and replacement of damaged bone or tooth zones in plastic and dental surgeries as well 
2 
 
as in coatings on dental and orthopaedic implants (Muster 1992; An et al. 2012; 
Oyefusi et al. 2014). Metals coated with hydroxyapatite have also been introduced as 
artificial bones. The hydroxyapatite coating will assist the surrounding tissue to bond 
firmly with the implant while the metal provides the strength for the artificial bone 
(Oonishi 1991; Mohseni et al. 2014; Pylypchuk et al. 2015).  
 
Hydroxyapatite is reported as a low soluble basic calcium phosphate with Ca/P 
ratio of 1.67 (Daniel Arcos 2014). It has consistent bioactive properties and therefore 
is well suited as a calcium phosphate coating for total joint arthoplasty and total knee 
arthoplasty. As a result of its biocompatible, nontoxic, and capable of bonding directly 
to bone, HAp possesses true osteointegration (Epinette 1999). However, although HAp 
offers high biocompatibility, relatively low density, high compressive strength and 
high hardness, application of HAp as a load bearing implant is limited because of its 
brittleness, relatively low mechanical properties and a high dissolution rate in body 
fluid. Hence, the necessity of reinforcement to HAp without hampering its 
biocompatibility plays a crucial role (Balani et al. 2009). 
 
Based on this understanding, the development of biocomposite materials is 
attractive as the advantage properties of two or more types of materials can be 
combined to suit better physical and mechanical properties of the matrix (Raucci et al. 
2016). The introduction of bioinert ceramics with better properties as reinforcement 
into HAp ceramic is one effective way in producing a biocomposite with acceptable 
strength in order to sustain the cyclic loading. Bioinert ceramics are chosen to enhance 
the properties of bioactive HAp because it can maintain their physical and mechanical 
properties while being implant in human body. Alumina (Al2O3), zirconia (ZrO2) and 
